Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 8-K Event Other events
  2. 8-K Event Other events
  3. 4 Option exercise Chief Financial Officer acquired 740 shares (option exercise)
  4. 4 Open-market sale Chief Medical Officer sold 1,760 shares at $18.58 ($32,699)
  5. 4 Open-market sale Director sold 25,000 shares at $20.50 ($512,500)
  6. CT ORDER Other Confidential Order
  7. 4 Open-market sale Chief Medical Officer sold 1,760 shares at $19.02 ($33,480)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Other events
  11. 4 Open-market sale Chief Financial Officer sold 9,291 shares at $18.56 ($172,472)
  12. 8-K Event Other events
  13. 4 Open-market sale Chief Medical Officer sold 1,760 shares at an average $15.01 ($26,415)
  14. 8-K Event Other events
  15. CT ORDER Other Confidential Order
  16. 4 Open-market sale Chief Medical Officer sold 1,760 shares at $15.00 ($26,400)
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 8-K Event Other events
  19. 8-K Event Material agreement · Shareholder vote results · Other events
  20. 424B5 Offering Prospectus

Page 28 of 47 · 923 filings